Macrolide antibiotics: current and future uses

Marie-Thérèse Labro1

  • 1INSERM, Paris, France. labro@bichat.inserm.fr

Insights

Macrolide antibiotics show potential beyond infection treatment, possibly by modulating inflammation or eliminating hidden pathogens. Research is ongoing to clarify their exact therapeutic mechanisms in inflammatory conditions.

Area of Science:

  • Pharmacology
  • Immunology
  • Infectious Diseases

Background:

  • Macrolide antibiotics have a well-established history in anti-infective therapy.
  • Emerging research suggests potential therapeutic applications for macrolides beyond their traditional antimicrobial roles.
  • Significant interest exists in their use for inflammatory diseases, including non-infectious conditions.

Purpose of the Study:

  • To investigate the therapeutic potential of macrolide antibiotics in inflammatory diseases.
  • To explore the underlying mechanisms by which macrolides may exert beneficial effects in inflammatory settings.
  • To address the ongoing debate regarding whether macrolides act as anti-inflammatory agents or eradicate unidentified chronic inflammatory triggers.

Main Methods:

  • Fundamental research studies.
  • Clinical therapeutic trials.
  • Analysis of host inflammatory responses and cellular targets.
  • Investigation of potential latent pathogen elimination.

Main Results:

  • Abundant fundamental research and therapeutic trials have been conducted worldwide.
  • The precise mechanisms of action for macrolides in inflammatory diseases remain under investigation.
  • No definitive conclusions have been reached regarding whether macrolides modulate host responses or eliminate pathogens.

Conclusions:

  • Macrolide antibiotics possess unexplored therapeutic potential, particularly in inflammatory conditions.
  • Further research is required to elucidate whether macrolides' benefits stem from immunomodulation or pathogen eradication.
  • The exact role of macrolides in treating inflammatory diseases is not yet clearly defined.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...